dc.contributor.advisor | 巫立宇 | zh_TW |
dc.contributor.advisor | Wu, Lei-Yu | en_US |
dc.contributor.author (Authors) | 廖文菁 | zh_TW |
dc.contributor.author (Authors) | Liao, Wen-Ching | en_US |
dc.creator (作者) | 廖文菁 | zh_TW |
dc.creator (作者) | Liao, Wen-Ching | en_US |
dc.date (日期) | 2020 | en_US |
dc.date.accessioned | 4-Jan-2021 10:57:13 (UTC+8) | - |
dc.date.available | 4-Jan-2021 10:57:13 (UTC+8) | - |
dc.date.issued (上傳時間) | 4-Jan-2021 10:57:13 (UTC+8) | - |
dc.identifier (Other Identifiers) | G0108932163 | en_US |
dc.identifier.uri (URI) | http://nccur.lib.nccu.edu.tw/handle/140.119/133423 | - |
dc.description (描述) | 碩士 | zh_TW |
dc.description (描述) | 國立政治大學 | zh_TW |
dc.description (描述) | 經營管理碩士學程(EMBA) | zh_TW |
dc.description (描述) | 108932163 | zh_TW |
dc.description.tableofcontents | 目次第一章 緒論 7第一節 研究背景和動機 7第二節 研究目的 8第三節 研究流程與架構 9第二章 文獻探討 10第一節 企業成長和經營策略的類型 10第二節 策略行銷分析4C架構 15第三章 產業分析 18第一節新藥開發產業概況和產業發展 18第二節 目前全球市場概況 21第三節 台灣的現況 22第四章 個案分析 24第一節 個案公司歷史發展與介紹 24第二節 個案公司主要優勢及產品服務 30第三節 個案公司之策略行銷分析 31第五章 結論與建議 33第一節 研究結論 33第二節 研究建議 34參考文獻 37 | zh_TW |
dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0108932163 | en_US |
dc.subject (關鍵詞) | 策略行銷分析: 4C架構 | zh_TW |
dc.subject (關鍵詞) | 醫藥研發服務公司 | zh_TW |
dc.subject (關鍵詞) | 臨床研究開發 | zh_TW |
dc.subject (關鍵詞) | 成長策略 | zh_TW |
dc.subject (關鍵詞) | Strategic marketing analysis: 4 C framework | en_US |
dc.subject (關鍵詞) | Pharmaceutical contract research organization | en_US |
dc.subject (關鍵詞) | Clinical research development | en_US |
dc.subject (關鍵詞) | Growth strategy | en_US |
dc.title (題名) | 跨國企業成長與策略行銷分析 -以醫藥研發服務Q公司為例 | zh_TW |
dc.title (題名) | Growth strategies & strategic marketing analysis - a pharmaceutical contract research organization company case | en_US |
dc.type (資料類型) | thesis | en_US |
dc.relation.reference (參考文獻) | 一、 中文部份1. 徐聯恩(譯) (民85年)。企業生命週期。(原作者: Ichak Adizes) 。台北市: 長河出版社。2. 邱志聖 (2014) 。策略行銷分析-架構與實務應用, 四版。台北市: 智勝文化。3. 葉嘉新、林志六 (2006) 。新藥開發與臨床試驗。台北市: 紅螞蟻圖書公司。二、 英文部份1. Finkelstein, S. and Hambrick, D.C. (1996). Strategic Leadership: Top Executives and their Effects on Organizations. St. Paul, MN: West Publishing.2. Hambrick, D. C. and Mason, P. (1984). Upper echelons: the organization as a reflection of its top anagers. Academy of Management Review: 9: 193-206.3. J. Mahoney & J. R. Pandian (1992). The Resource-Based View within the Conversation of Strategic Management. Strategic Management Journal: 12, 363-80 16.4. Penrose, E. (1995). The Theory of the Growth of the Firm. New York: Oxford University Press.5. Chandler, A. D. (1990). Strategy and structure: chapters in the history of the industrial enterprise. Cambridge: Mass: M.I.T. Press.6. F. J. Aguilar (1967). Scanning the Business Environment. New York : MacMillan Co.7. Glueck, W.F. (1976). Business Policy: Strategy Formulation and Management Action. 2nd ed. New York: McGraw-Hill.8. Miles, Ramond E. and Charles C. Snow (1978). Organizational Strategy, Structure and Process. New York: McGraw-Hill.9. Porter, M. E. (1980). Competitive Strategy: Techniques for Analyzing Industries and Competitors. New York: Free Press.10. Ansoff, H (1988). The New Corporate Strategy. New York: John Wiley and Sons.11. Kolter, P. (1984). Marketing Management Analysis, Planning and Controls. New Jersey: Prentice-Hall.12. Hofer, C. & Schendel, D.(1978). Strategy Formulation: Analytical concepts. Minnesota: West.13. Robbins, S. P. (1990). Organization theory: Structure, design and application. New Jersey: Prentice-Hall.三、 網路資料1. 邱志聖,策略行銷分析4C架構新知網站: http://sma4c.blogspot.com/2012/12/4c101.html2. 泛科學,2009: https://pansci.asia/archives/385293. American Council On Science And Health, 2020: https://www.acsh.org/news/2020/06/11/clinical-trial-success-rates-phase-and-therapeutic-area-148454. 財團法人醫藥品查驗中心, 2020: https://www.cde.org.tw/drugs/5. IQVIA: 維基百科:https://en.wikipedia.org/wiki/IQVIA6. IQVIA 網站: https://www.iqvia.com/ | zh_TW |
dc.identifier.doi (DOI) | 10.6814/NCCU202001853 | en_US |